Pattern and Molecular Mechanisms of Cardiac Troponin Release in Conditions Other than Acute Coronary Syndromes

Authors

  • Kosit Sribhen Department of Clinical Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700
  • Choosri Sribhen Department of Physiology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900

Keywords:

No Keyword

Abstract

No Abstract

References

1. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task
Force for the Redefinition of Myocardial Infarction. Universal definition
of myocardial infarction. Eur Heart J. 2007 Oct;28(20):2525-38.
2. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction
redefined--a consensus document of The Joint European Society of Cardiology/
American College of Cardiology Committee for the redefinition of
myocardial infarction. J Am Coll Cardiol. 2000 Sep;36(3):959-69.
3. Eggers KM, Lind L, Venge P, Lindahl B. Will the universal definition of
myocardial infarction criteria result in an overdiagnosis of myocardial
infarction? Am J Cardiol. 2009 Mar 1;103(5):588-91.
4. Apple FS, Pearce LA, Smith SW, Kaczmarek JM, Murakami MM. Role
of monitoring changes in sensitive cardiac troponin I assay results for
early diagnosis of myocardial infarction and prediction of risk of adverse
events. Clin Chem. 2009 May;55(5):930-7.
5. Wu AH, Lu QA, Todd J, Moecks J, Wians F. Short- and long-term biological
variation in cardiac troponin I measured with a high-sensitivity
assay : implications for clinical practice. Clin Chem. 2009 Jan;55(1):52-8.
6. Vasile VC, Saenger AK, Kroning JM, Jaffe AS. Biological and analytical
variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem.
2010 Jul;56(7):1086-90.
7. NACB Writing Group, Wu AH, Jaffe AS, Apple FS, Jesse RL, Francis
GL, et al. National Academy of Clinical Biochemistry Laboratory Medicine
Practice Guidelines : Use of cardiac troponin and B-type natriuretic peptide
or N-terminal pro B-type natriuretic peptide for etiologies other than acute
coronary syndromes and heart failure. Clin Chem. 2007 Dec;53(12):2086-
96.
8. Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, OัConnor CM, Felker
GM. Troponin elevation in heart failure. Prevalence, mechanism, and
clinical implications. J Am Coll Cardiol. 2010 Sep 28;56(14):1071-8.
9. Braunwald E. Biomarkers in heart failure. N Engl J Med. 2008 May
15;358(20):2148-59.
10. Nef HM, Moellmann H, Akashi YJ, Hamm CW. Mechanism of stress
(Takotsubo) cardiomyopathy. Nat Rev Cardiol. 2010 Apr;7(4):187-93.
11. Lyon AR, Rees PSC, Prasad S, Poole-Wilson PA, Harding SE. Stress
(Takotsubo) cardiomyopaty: a novel pathophysiological hypothesis to
explain catecholamine-induced acute myocardial stunning. Nat Clin Pract
Cardiovasc Med. 2008 Jan;5(1):22-9.
12. van der Bilt IA, Hasan D, Vandertop WP, Wilde AA, Algra A, Visser
FC, et al. Impact of cardiac complications on outcome after aneurysmal
subarachnoid hemorrhage. A meta analysis. Neurology. 2009 Feb 17;72(7):
635-42.
13. Song HS, Bach JH, Jin DK, Chung PW, Moon HS, Suh BC, et al. Cardiac
troponin T elevation after stroke : Relationships between elevated serum
troponin T, stroke location, and prognosis. J Clin Neurol. 2008 Jun;4(2):75-
83.
14. Goh YS, Tong KL. Phaeochromocytoma the great mimicker : A case
report. Ann Acad Med Singapore. 2008 Jan;37(1):79-81.
15. Menke-van der Houven van Oordt CW, Twickler TB, van Asperdt FG,
Ackermans P, Timmers HJ, Hermus AR. Phaeochromocytoma mimicking
an acute myocardial infarction. Neth Heart J. 2007;15(7-8):248-51.
16. Schwartz BG, Rezkalla S, Kloner RA. Cardiovascular effects of cocaine.
Circulation. 2010 Dec 14;122(24):2558-69.
17. Egred M, Davis GK. Cocaine and the heart. Postgrad Med J. 2005 Sep;81
(959):568-71.
18. Gray SD, Fatovich DM, McCoubrie DL, Daly FF. Amphetamine-related
presentations to an inner-city tertiary emergency department: a prospective
evaluation. Med J Aust. 2007 Apr 2;186(7):336-9.
19. Turnipseed SD, Richards JR, Kirk JD, Diercks DB, Amsterdam EA.
Frequency of acute coronary syndrome in patients presenting to the
emergency department with chest pain after methamphetamine use. J
Emerg Med. 2003 May;24(4):369-73.
20. Regwan S, Hulten EA, Martinho S, Slim J, Villines TC, Mitchell J, et al.
Marathon running as a cause of troponin elevation : A systemic review
and meta-analysis. J Interv Cardiol. 2010 Oct;23(5):443-50.
21. Shave R, Baggish A, George K, Wood M, Scharhag J, Whyte G, et al.
Exercise-induced cardiac troponin elevation. Evidence, mechanisms, and
implications. J Am Coll Cardiol. 2010 Jul 13;56(3):169-76.
22. Sribhen K, Sribhen C. Stress-related myocardial damage and dysfunction :
Biochemical and pathophysiological considerations. Siriraj Med J 2008:
Jan-Feb 60(1): 46-50.
23. Mann DL, Kent RL, Parsons B, Cooper G. Adrenergic effects on the
biology of the adult mammalian cardiocyte. Circulation. 1992 Feb;85(2):
790-804.
24. Bertinchant JP, Robert E, Polge A, Marty-Double C, Fabbro-Peray P,
Poirey S, et al. Comparison of the diagnostic value of cardiac troponin I
and T determinations for detecting early myocardial damage and the relationship
with histological findings after isoprenaline-induced cardiac injury
in rats. Clin Chim Acta. 2000 Aug;298(1-2):13-28.
25. Abraham J, Mudd JD, Kapur N, Klein K, Champion HC, Wittstein IS.
Stress cardiomyopathy after intravenous administration of catecholamines
and beta-receptor agonists. J Am Coll Cardiol. 2009 Apr 14;53(15):1320-5.
26. Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Scott Wright R,
et al. Systemic review : transient left ventricular apical ballooning : a
syndrome that mimics ST-segment elevation myocardial infarction. Ann
Intern Med. 2004 Dec 7;141(11):858-65.
27. Wittstein IS, Thiemann DR, Lima JAC, Baughman KL, Schulman SP,
Gerstenblith G, et al. Neurohumoral features of myocardial stunning due
to sudden emotional stress. N Engl J Med. 2005 Feb 10;352(6):539-48.
28. Mann DL. Basic mechanisms of disease progression in the failing heart :
the role of excessive adrenergic drive. Prog Cardiovasc Dis. 1998 Jul-Aug;
41(1 Suppl 1):1-8.
29. Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000 Nov 9;343
(19):1388-98.
30. Oakley CM. Myocarditis, pericarditis, and other pericardial diseases. Heart.
2000 Oct;84(4):449-54.
31. Altmann DR, Korte W, Maeder MT, Fehr T, Haager P, Rickli H, et al.
Elevated cardiac troponin I in sepsis and septic shock : No evidence for
thrombus associated myocardial necrosis. PLoS ONE 2010 Feb; 5(2):
e9017.
32. Wu AHB. Increased troponin in patients with sepsis and septic shock :
myocardial necrosis or reversible myocardial depression? Intensive Care
Med. 2001;27:959-61.
33. Oppeltz RF, Zhang Q, Rani M, Sasaki JR, Schwacha MG. Increased
expression of cardiac IL-17 after burn. J Inflamm (Lond). 2010 Jul 27;
7:38.
34. Barber RC, Maass DL, White DJ, Horton JW. Increasing percent burn is
correlated with increasing inflammation in an adult rodent model. Shock.
2008 Oct;30(4):388-93.
35. Cardinale D, Sandri MT. Role of biomarkers in chemotherapy-induced
cardiotoxicity. Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):121-9.
36. Cardinale D, Sandri MT, Colombo A, Colombo N, Boeri M, Lamantia G,
et al. Prognostic value of troponin I in cardiac risk stratification of cancer
patients undergoing high-dose chemotherapy. Circulation. 2004 Jun 8;109
(22):2749-54.
37. Sawyer DB, Peng X, Chen B, Pentassuglia L, Lim CC. Mechanisms of
anthracycline cardiac injury : can we identify strategies for cardioprotection?
Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):105-13.
38. Giroir BP, Horton JW, White DJ, McIntyre KL, Lin CQ. Inhibition of
tumor necrosis factor prevents myocardial dysfunction during burn shock.
Am J Physiol. 1994 Jul;267(1 Pt 2):H118-24.
39. Adamcova M, Simunek T, Kaiserova H, Popelova O, Sterba M, Potacova
A, et al. In vitro and in vivo examination of cardiac troponins as biochemical
markers of drug-induced cardiotoxicity. Toxicology. 2007 Jul
31;237(1-3):218-28.
40. Nie J, Close G, George KP, Tong TK, Shi Q. Temporal association of
elevations in serum cardiac troponin T and myocardial oxidative stress
after prolonged exercise in rats. Eur J Appl Physiol. 2010 Dec;110(6):1299-
303.
41. Wagner KH, Reichhold S, Hoelzl C, Knasmueller S, Nics L, Meisel M,
et al. Well-trained, healthy triathletes experience no adverse health risks
regarding oxidative stress and DNA damage by participating in an ultraendurance
event. Toxicology. 2010 Dec 5;278(2):211-6.

Downloads

Published

03-04-2020

How to Cite

Sribhen, K. ., & Sribhen, C. . (2020). Pattern and Molecular Mechanisms of Cardiac Troponin Release in Conditions Other than Acute Coronary Syndromes. Siriraj Medical Journal, 63(4), 139–142. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/240988

Issue

Section

Review Article